These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35781334)

  • 1. Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry.
    Nabeta T; Kitai T; Naruse Y; Taniguchi T; Yoshioka K; Tanaka H; Okumura T; Sato S; Baba Y; Kida K; Tamaki Y; Matsumoto S; Matsue Y
    Eur Heart J; 2022 Sep; 43(36):3450-3459. PubMed ID: 35781334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Value of B-Type Natriuretic Peptide in Patients With Cardiac Sarcoidosis Without Heart Failure: Insights From ILLUMINATE-CS.
    Miyakuni S; Maeda D; Matsue Y; Yoshioka K; Dotare T; Sunayama T; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Matsumura A; Minamino T
    J Am Heart Assoc; 2022 Dec; 11(24):e025803. PubMed ID: 36515231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE-CS study.
    Maeda D; Matsue Y; Dotare T; Sunayama T; Iso T; Yoshioka K; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Minamino T
    Eur J Heart Fail; 2024 Jan; 26(1):77-86. PubMed ID: 37823255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of Mild to Moderate Impairment of Left Ventricular Ejection Fraction With Fatal Ventricular Arrhythmic Events in Cardiac Sarcoidosis.
    Akama Y; Fujimoto Y; Matsue Y; Maeda D; Yoshioka K; Dotare T; Sunayama T; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Sato S; Tanaka H; Okumura T; Baba Y; Minamino T
    J Am Heart Assoc; 2024 Mar; 13(6):e032047. PubMed ID: 38456399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of outcome in a contemporary cardiac sarcoidosis population: Role of brain natriuretic peptide, left ventricular function and myocardial inflammation.
    Kouranos V; Khattar RS; Okafor J; Ahmed R; Azzu A; Baksi JA; Wechalekar K; Cowie MR; Wells AU; Lüscher TF; Sharma R
    Eur J Heart Fail; 2023 Dec; 25(12):2287-2298. PubMed ID: 37877328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis.
    Iso T; Maeda D; Matsue Y; Dotare T; Sunayama T; Yoshioka K; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Minamino T
    Heart; 2023 Aug; 109(18):1387-1393. PubMed ID: 37185298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias.
    Crawford T; Mueller G; Sarsam S; Prasitdumrong H; Chaiyen N; Gu X; Schuller J; Kron J; Nour KA; Cheng A; Ji SY; Feinstein S; Gupta S; Ilg K; Sinno M; Abu-Hashish S; Al-Mallah M; Sauer WH; Ellenbogen K; Morady F; Bogun F
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1109-15. PubMed ID: 25266311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT.
    Medina A; Moss AJ; McNitt S; Zareba W; Wang PJ; Goldenberg I
    Heart Rhythm; 2016 Apr; 13(4):852-9. PubMed ID: 26724489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-related differences in the prognosis of patients with cardiac sarcoidosis treated with cardiac resynchronization therapy.
    Nakasuka K; Ishibashi K; Hattori Y; Mori K; Nakajima K; Nagayama T; Kamakura T; Wada M; Inoue Y; Miyamoto K; Nagase S; Noda T; Aiba T; Takaya Y; Isobe M; Terasaki F; Ohte N; Kusano K
    Heart Rhythm; 2022 Jul; 19(7):1133-1140. PubMed ID: 35257978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis and risk stratification in cardiac sarcoidosis patients with preserved left ventricular ejection fraction.
    Chiba T; Nakano M; Hasebe Y; Kimura Y; Fukasawa K; Miki K; Morosawa S; Takanami K; Ota H; Fukuda K; Shimokawa H
    J Cardiol; 2020 Jan; 75(1):34-41. PubMed ID: 31277963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Prognostic Significance of Ventricular Repolarization Dispersion in Patients with Cardiac Sarcoidosis.
    Kobayashi Y; Nagai T; Takenaka S; Kato Y; Komoriyama H; Nagano N; Kamiya K; Konishi T; Sato T; Omote K; Tsujinaga S; Iwano H; Kusano K; Yasuda S; Ogawa H; Ishibashi-Ueda H; Anzai T
    Am J Cardiol; 2021 Aug; 152():125-131. PubMed ID: 34127248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: comparison between heart failure subtypes based on left ventricular ejection fraction.
    Fujimoto H; Doi N; Okayama S; Naito M; Kobori A; Kaitani K; Inoue K; Kurotobi T; Morishima I; Yamaji H; Matsui Y; Nakazawa Y; Kusano K; Hirai K; Nakai T; Suzuki M; Yano H; Sakai S; Kimura T; Shizuta S; Saito Y;
    Europace; 2022 Apr; 24(4):576-586. PubMed ID: 34463733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and prognostic value of atrial fibrillation in patients with cardiac sarcoidosis.
    Fujimoto Y; Matsue Y; Maeda D; Dotare T; Sunayama T; Iso T; Nakamura Y; Singh YS; Akama Y; Yoshioka K; Kitai T; Naruse Y; Taniguchi T; Tanaka H; Okumura T; Baba Y; Nabeta T; Minamino T
    Eur Heart J Open; 2023 Sep; 3(5):oead100. PubMed ID: 37849788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review.
    Papageorgiou N; Providência R; Bronis K; Dechering DG; Srinivasan N; Eckardt L; Lambiase PD
    Europace; 2018 Apr; 20(4):682-691. PubMed ID: 28444174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of cardiac sarcoidosis after radiofrequency ablation and placement of AICD- A propensity matched analysis.
    Bandyopadhyay D; Sahoo D; Zein J; Brunken RC; Tchou PJ; Culver DA
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):70-9. PubMed ID: 26237358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.
    Bunch TJ; Weiss JP; Crandall BG; Day JD; May HT; Bair TL; Osborn JS; Mallender C; Fischer A; Brunner KJ; Mahapatra S
    Heart Rhythm; 2014 Apr; 11(4):533-40. PubMed ID: 24333283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of serial quantitative evaluation of
    Muser D; Santangeli P; Castro SA; Liang JJ; Enriquez A; Werner TJ; Nucifora G; Magnani S; Hayashi T; Zado ES; Garcia FC; Callans DJ; Dixit S; Desjardins B; Marchlinski FE; Alavi A
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1394-1404. PubMed ID: 29610956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.